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Adult rat skeletal muscle does not express detectable vels of neural cell adhesion molecule (N-CAM) and 
membrane activity mediated by nerve appears to repress the N-CAM gene. N-CAM expression i skeletal 
muscle can however be reinduced by hypothyroidism. Thyroidectomised rats re-express N-CAM mRNAs 
of 5.2 and 2.9 kb and Western blot analysis howed protein bands of 125 and 155 kDa. Immunofluorescence 
analysis also showed high levels of N-CAM in the sarcolemma. These changes in N-CAM expression could 
be reversed by treatment of hypothyroid rats with thyroxine. Thus thyroid hormones as well as neural in- 
fluences appear to control N-CAM expression i skeletal muscle. 
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1. INTRODUCTION 
A number of studies have shown the neural cell 
adhesion molecule (N-CAM) to be expressed in 
skeletal muscle [1-9]. High levels of N-CAM are 
found in cell cultures of skeletal muscle [1,4,7,8] 
and also in embryonic muscle [1,5,7,9] correlating 
with the processes of myofibre formation and 
polyneuronal innervation. N-CAM in the muscle 
sarcolemma is down-regulated neonatally [ 1,5,7,9] 
and expression is confined mainly to the 
neuromuscular junction in adult muscle [1,5,6]. 
Synaptic activity has been found to regulate N- 
CAM expression since denervation [2,5,6], 
paralysis [6] or botulinum toxin treatment [2] has 
been found to cause a reactivation of N-CAM ex- 
pression. All these changes in N-CAM expression 
are accompanied by qualitative and quantitative 
changes in individual N-CAM protein and mRNA 
species. The major desialo N-CAM isoform in 
myoblasts is a transmembrane isoform of about 
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140--145 kDa (N-CAM-145) while myotubes ex- 
press predominantly non-transmembrane d sialo 
isoforms of about 155 kDa (N-CAM-155) and 
125 kDa (N-CAM-125) [5,8-10]. These protein 
changes are accompanied by changes in mRNA 
species. Myoblasts predominantly express a 6.7 kb 
species that encodes N-CAM-145 while myotubes 
express 5.2 and 2.9 kb species in rodents and 5.2 
and 4.3 kb species in human muscle that encode N- 
CAM-155 and N-CAM-125 [8,10]. Alternative 
RNA splicing has been found to introduce a 
muscle-specific sequence into the extracellular do- 
main of N-CAM-125 and N-CAM-155 but not a 
brain homologue of 120 kDa (N-CAM-120) show- 
ing that the maturation of skeletal muscle is ac- 
companied by the operation of a muscle-specific 
splicing mechanism [11]. The plasticity of gene ex- 
pression in skeletal muscle is well documented and 
a variety of physiological and hormonal stimuli 
have been found to be important controlling 
mechanisms [12]. To analyse the plasticity of N- 
CAM expression in skeletal muscle we analysed the 
effects of thyroid hormones, a model system that 
has been extensively used to study isoform transi- 
tions in myosin heavy chain (MHC) genes [13-17]. 
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2. MATERIALS AND METHODS 
Young male rats (Sprague Dawley, 150 g) were 
thyroidectomised and skeletal muscle analysed at 
various time points up to 59 days. Treatment of 
hypothyroid rats with T4 was carried out by 3 in- 
traperitoneal injections per week of 1/~g T4 in 
250/A saline. 
For Northern blot analysis total RNA was 
isolated from leg muscle at appropriate time 
points, run on agarose gels, transferred to 
nitrocellulose and hybridised with the N-CAM 
probe pMI.3 [13] as described [14,15]. Im- 
munoblot and indirect immunofluorescence 
analysis of N-CAM in control and 33-day 
hypothyroid rats and human hypothyroid 
myopathy samples was carried out as in [1]. The N- 
CAM antibody used was rabbit anti-N-CAM and 
the detecting antibody was fluorescein-labelled 
goat anti-rabbit immunoglobulin. 
1 2 3 4 5 6 7 8 9 10 11 
5"2 
42.9 
Fig.1. Northern blot analysis of control, hypothyroid 
and T4-treated muscle samples with N-CAM cDNA 
probe. Lanes: 1, newborn rat muscle; 2,3, adult rat 
muscle; 4-8, hypothyroid rat muscle after (4) 7 days, (5) 
23 days, (6) 33 days, (7) 38 days and (8) 59 days of 
hypothyroidism; 9-11, samples of muscle from 29-day 
hypothyroid rats after 4 days (9), 9 days (10) and 30 days 
(1 l) of T4 treatment. 
3. RESULTS 
To determine whether thyroid hormones 
regulate muscle N-CAM expression, we made rats 
hypothyroid by thyroidectomy. Muscle samples 
were analysed at various time points after the le- 
sion. A Northern blot analysis was first carried out 
to assess changes in N-CAM mRNA species. 
Newborn rats express mRNAs of 5.2 and 2.9 kb, 
whereas adult rats do not express appreciable 
amounts of N-CAM mRNA (fig.l). Muscle 
samples from hypothyroid rats were taken from 7 
days and up to 59 days after the lesion and com- 
pared to control muscle samples. Control muscle 
samples did not express N-CAM mRNA. In con- 
trast, hypothyroid rats expressed 5.2 and 2.9 kb 
mRNA transcripts at 23 days and this increased at 
later time points taken at 33, 38 and 59 days 
(fig.l). No evidence was found for the third N- 
CAM mRNA species of 6.7 kb that is found in 
myoblasts uggesting that the N-CAM mRNA that 
is found is predominantly expressed in myofibres. 
Thyroid hormone deficiency can be reversed by ad- 
ministration of T4 and we therefore treated rats 
that had been hypothyroid for 29 days with T4 for 
4, 9 or 30 days (fig.l). As little as 4 days of T4 
treatment was sufficient to down-regulate the 5.2 
and 2.9 kb mRNAs and no transcripts were found 
after 9 and 30 days of T4 treatment showing that 
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Fig.2. Immunoblot analysis of N-CAM in control and 
33-day hypothyroid rats. The blot shows control (l) or 
hypothyroid muscle (2) and the same samples after 
treatment with neuraminidase to generate desialo N- 
CAM (track 3, control; track 4, hypothyroid muscle). 
the changes in N-CAM gene expression were fully 
reversible. To determine whether the activation of 
N-CAM mRNA resulted in specific N-CAM pro- 
tein expression, an immunoblot analysis was car- 
ried out. Fig.2 shows that rat muscle from control 
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animals has barely detectable levels of N-CAM 
whereas 33-day hypothyroid animals express high 
levels of N-CAM. Desialo N-CAM was generated 
by neuraminidase treatment to relate the isoforms 
found in hypothyroid muscle to those previously 
found in muscle tissue. N-CAM-125 and N- 
CAM-155 are the predominant desialo N-CAM 
band found in hypothyroid muscle consistent with 
the presence of 5.2 and 2.9 kb mRNA species 
(fig.2). Indirect immunofluorescence was used to 
analyse the location of N-CAM in muscle (fig.3). 
Control rat muscle does not express N-CAM at the 
sarcolemma but there is a very weak reactivity 
associated with satellite cells (fig.3a) [7]. Animals 
that were hypothyroid for 28 days showed strong 
N-CAM staining at the sarcolemma nd in addi- 
tion, there was variable staining of the myofibre 
cytoplasm similar to that found in other lesions of 
neuromuscular t ansmission [2,5,6] (fig.3b). To 
O 
determine whether these high levels of muscle N- 
CAM were specific to experimental hypothy- 
roidism, biopsies of humans with hypothyroid 
myopathy were examined. Control adult human 
muscle does not express N-CAM as was shown 
previously [3] (fig.3c). However, in hypothyroid 
myopathy there was strong staining of the muscle 
sarcolemma nd cytoplasm (fig.3d). Thus, the 
observed changes in N-CAM expression in ex- 
perimental hyothyroidism correlate well with 
changes found in human neuromuscular disease 
and show the generality of the observations. 
4. DISCUSSION 
A number of studies have analysed N-CAM ex- 
pression in developing and adult skeletal muscle 
and in adult muscle subjected to a variety of classic 
lesions of neuromuscular t ansmission [1-9]. A 
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Fig.3. Indirect immunofluorescence analysis of N-CAM in control rat (a), 33-day hypothyroid rats (b), control human 
(c) and human hypothyroid myopathy (d) samples. Scale bar represents 100/zm. 
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general picture has emerged showing that N-CAM 
is present in embryonic muscle but not adult mus- 
cle and that denervation or paralysis reinduces N- 
CAM expression implying that muscle activity ap- 
pears to control N-CAM levels. These data are 
consistent with a role for N-CAM controlling the 
innervation potential of myofibres and suggest 
that N-CAM down-regulation may be a functional 
signal in the shift from polyneuronal innervation 
to monosynaptic input. However, there is only a 
very general association between the timing of 
withdrawal of polyneuronal innervation and N- 
CAM levels and other parallels such as a shift from 
a hypothyroid state at birth to a neonatal 
euthyroid state [16] can also be made. In addition, 
the neonatal down-regulation of N-CAM mediated 
by activity is difficult to reconcile with studies on 
chick embryos that show a synchronous down- 
regulation of N-CAM in primary and secondary 
myofibres that are innervated at different times 
and in human muscle diseases uch as myotonic 
dystrophy, where there are high levels of sarcolem- 
mal N-CAM and no evidence of impairment of 
neuromuscular transmission (Walsh, unpub- 
lished). These studies suggest that innervation 
status may not be the sole controlling element in N- 
CAM expression in muscle and that other in- 
fluences uch as hormones, growth factors or other 
unidentified factors may be important. Thyroid 
hormones have been shown to regulate MHC genes 
in highly specific ways in skeletal and cardiac mus- 
cle [16-20]. Hypothyroidism reinduces embryonic 
MHC in soleus muscle and neonatal MHC in 
masseter muscle [19,20] showing that gene 
products that are not normally expressed in adult 
muscle can be reinduced by hypothyroidism. N- 
CAM is one additional muscle gene product whose 
expression is controlled in part by hormonal status 
and it seems likely that a complex interplay of hor- 
monal and neural influences determines final N- 
CAM levels. 
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